<DOC>
	<DOCNO>NCT01826175</DOCNO>
	<brief_summary>Subjects acute coronary syndrome schedule cardiac catheterization enrol study . Subjects treat clinically coronary artery stenting randomize receive loading dose clopidogrel versus ticagrelor diagnostic angiography prior stenting . Optical coherence tomography ( OCT ) perform stenting presence blood clot inside new stent measure compare group .</brief_summary>
	<brief_title>Comparison Ticagrelor Versus Clopidogrel Residual Thrombus Burden During PCI : OCT Study</brief_title>
	<detailed_description>Subjects acute coronary syndrome schedule cardiac catheterization enrol study . Subjects treat clinically coronary artery stenting randomize receive loading dose clopidogrel versus ticagrelor diagnostic angiography prior stenting . Optical coherence tomography ( OCT ) perform stenting presence blood clot inside new stent measure compare group</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Patient Characteristics : 1 . Males nonpregnant female &gt; 18 &lt; 79 year age present acute coronary syndrome define two follow criterion : 1 . Signs symptoms consistent accelerate angina prolong angina ( last great 20 minute ) either rest minimal exertion 2 . ECG change indicative new ischemia 3 . Levels cardiac biomarkers ( troponinT ) upper limit normal range . 2 . Patients schedule undergo coronary angiography possible percutaneous coronary intervention ( PCI ) Lesion Characteristics Diagnostic Coronary Angiography 1 . De novo lesion native coronary artery find diagnostic coronary angiography 2 . Angiographic stenosis &lt; 100 % 3 . Reference vessel diameter 2.5 mm 4.0 mm visual estimation General Exclusion Criteria 1 . Subjects unable unwilling sign inform consent form 2 . Subjects treat antiplatelet medication aspirin prior diagnostic catheterization include glycoprotein IIb/IIIa inhibitor . 3 . Subjects serious comorbid condition judgment investigator preclude inclusion study 4 . Subjects NYHA class III IV heart failure know leave ventricular ejection fraction &lt; 30 % 5 . Subjects ST elevation myocardial infarction 6 . Subjects hemodynamic electrical instability ( include shock ) 7 . Subjects diagnose severe , noncatheterrelated coronary artery spasm 8 . Subjects may pregnant 9 . Subjects know allergy contrast medium 10 . Subjects renal failure define eGFR &lt; 60 . 11 . History TIA stroke &lt; 6 month 12 . History hemorrhagic stroke 13 . Hepatic insufficiency define liver cirrhosis , AST/ALT/Alkaline Phosphatase great 3 time upper limit normal hyperbilirubinemia . Lesion Specific Exclusion Criteria These exclusion criterion apply target lesion image OCT. 1 . Lesion locate leave main coronary artery 2 . Lesions heavily calcify 3 . Lesions OCT perform due technical difficulty 4 . Other lesion investigator deems inappropriate procedure sit excessive tortuosity low flow TIMI grade . 5 . Lesion saphenous vein arterial conduit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Optical Coherence Tomography</keyword>
	<keyword>ticagrelor</keyword>
	<keyword>clopidogrel</keyword>
</DOC>